Latest ZaBeCor Pharmaceuticals Stories
ZaBeCor Pharmaceuticals, a biotechnology company, has announced that the FDA has approved the company's investigational new drug application for the treatment of asthma. This approval enables the company to proceed with Phase I clinical trials in humans for its asthma drug candidate, Excellair.
US-based biotechnology company ZaBeCor Pharmaceuticals has announced the formation of its new subsidiary Biothorpe Pharmaceuticals, a biotechnology company focused on the development of siRNA, antisense and other molecular technologies for the treatment of cancer.
- A poem in which the author retracts something said in an earlier poem.